pharma · Amyotrophic Lateral Sclerosis · Acute Myeloid Leukemia
AB Science
AB Science patent portfolio — 15 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- PARIS, FR
- Employees
- 20
- Programs
- 0
- Drugs
- 4
- Patents
- 15
AB Science patents
15 pharmaceutical patents indexed for AB Science. 0 expire within 24 months.
AB Science has 15 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
CA 3217490
MASITINIB POUR LE TRAITEMENT DU CANCER DE LA PROSTATE RESISTANT A LA CASTRATION
granted -
CA 3201259
MASITINIB POUR LE TRAITEMENT DE LA MALADIE D'ALZHEIMER
granted -
CA 3174748
UTILISATION DE MASITINIB POUR LE TRAITEMENT DE LA MALADIE A CORONAVIRUS 2019 (COVID-19)
granted -
CA 3168610
MASITINIB POUR LE TRAITEMENT D'UNE SOUS-POPULATION DE PATIENTS SOUFFRANT DE SCLEROSE EN PLAQUES
granted -
EP 3831384
VERWENDUNG VON MASITINIB ZUR BEHANDLUNG VON EOSINOPHILEM ASTHMA
granted -
WO 2021099616
MASITINIB POUR LE TRAITEMENT DE LA DRÉPANOCYTOSE
granted -
CA 3018635
UTILISATION DE MASITINIB POUR LE TRAITEMENT D'UNE SOUS-POPULATION DE PATIENTS ATTEINTS DE SCLEROSE LATERALE AMYOTROPHIQUE
granted -
WO 2017072335
UTILISATION DE MASITINIB ET D'AUTRES INHIBITEURS DE MASTOCYTE POUR LE TRAITEMENT DE LA MALADIE DE PARKINSON
granted -
US 2017119760
USE OF MASITINIB FOR THE TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY
granted -
CA 3000894
TRAITEMENT DE LA MASTOCYTOSE SYSTEMIQUE GRAVE PAR LE MASITINIB
granted -
US 2017020867
USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASE
granted -
WO 2016096933
MASITINIB COMBINÉ À UTILISER DANS LE TRAITEMENT DU CANCER DU SEIN
granted -
US 2016175302
MASITINIB FOR TREATING GASTRIC CANCER
granted -
US 2016128999
MASITINIB FOR TREATING HEPATIC CANCER
granted -
US 2016089368
TREATMENT OF MASTOCYTOSIS WITH MASITINIB
granted
Frequently asked questions
How many patents does AB Science have?
15 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do AB Science patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.